Loading...
A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA)
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory arthritis, with significant impact on quality of life and functional status. Whilst biologic disease modifying anti-rheumatic drugs (bDMARD) such as tumour necrosis factor-inhibitor (TNFi) agents have revolutionised outcomes in RA, earl...
Na minha lista:
Udgivet i: | BMC Musculoskelet Disord |
---|---|
Main Authors: | , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4743173/ https://ncbi.nlm.nih.gov/pubmed/26847108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-0915-0 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|